These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 3768254)
21. Theophylline levels and clinical response in asthmatic adults receiving long-term Uniphyl. Petty TL; Rollins DL Am J Med; 1985 Dec; 79(6A):73-6. PubMed ID: 2867679 [TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children]. Iwasaki E; Baba M Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433 [TBL] [Abstract][Full Text] [Related]
23. Theophylline minimally inhibits bronchoconstriction induced by dry cold air inhalation in asthmatic subjects. Merland N; Cartier A; L'Archevêque J; Ghezzo H; Malo JL Am Rev Respir Dis; 1988 Jun; 137(6):1304-8. PubMed ID: 3202370 [TBL] [Abstract][Full Text] [Related]
24. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation. Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217 [TBL] [Abstract][Full Text] [Related]
25. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration. Katz RM; Rachelefsky GS; Siegel SC; Mickey R Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515 [TBL] [Abstract][Full Text] [Related]
26. A comparative study of the use of choline theophyllinate and a sustained-release theophylline in adults with chronic asthma. Chan KW; Lee HS; Ti TY; Tan TH; Feng PH Ann Acad Med Singap; 1985 Jul; 14(3):470-4. PubMed ID: 4073814 [TBL] [Abstract][Full Text] [Related]
27. Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma. Reinberg A; Pauchet F; Ruff F; Gervais A; Smolensky MH; Levi F; Gervais P; Chaouat D; Abella ML; Zidani R Chronobiol Int; 1987; 4(3):409-19. PubMed ID: 3315270 [TBL] [Abstract][Full Text] [Related]
28. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma. Pedersen S; Steffensen G J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612 [TBL] [Abstract][Full Text] [Related]
29. Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma. Hibberd SG; Alveyn C; Coombes EJ; Holgate ST Br J Clin Pharmacol; 1986 Sep; 22(3):337-41. PubMed ID: 3768245 [TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical effects and pharmacokinetics of once-daily Uniphyl and twice-daily Theo-Dur in asthmatic patients. Fairshter RD; Bhola R; Thomas R; Wilson AF; Hyatt J; Snapp S; Cummins L Am J Med; 1985 Dec; 79(6A):48-53. PubMed ID: 4083298 [TBL] [Abstract][Full Text] [Related]
31. Determinants of free theophylline clearance in asthma. Williams PE; Alwazir YA; Littley M; Buss DC; John R; Campbell IA; Routledge PA; Lazarus JH Br J Clin Pharmacol; 1987 Nov; 24(5):655-9. PubMed ID: 3435693 [TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic and spirometric responses to a sustained-release theophylline capsule. Falliers CJ Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):125-30. PubMed ID: 429083 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of sustained release theophylline given at three different evening intake times in addition to a baseline medication. Siebert B; Kunkel G; Borner K; Staudinger HW; Steinijans VW Eur Respir J; 1990 Feb; 3(2):176-81. PubMed ID: 2178965 [TBL] [Abstract][Full Text] [Related]
34. Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. Martin RJ; Cicutto LC; Ballard RD; Goldenheim PD; Cherniack RM Am Rev Respir Dis; 1989 Feb; 139(2):475-8. PubMed ID: 2913892 [TBL] [Abstract][Full Text] [Related]
35. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation. Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062 [No Abstract] [Full Text] [Related]
37. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Crescioli S; Spinazzi A; Plebani M; Pozzani M; Mapp CE; Boschetto P; Fabbri LM Ann Allergy; 1991 Mar; 66(3):245-51. PubMed ID: 2006773 [TBL] [Abstract][Full Text] [Related]
38. Comparison of two dosage schedules of sustained release theophylline in pediatric patients. Loren ML; Kirsten EB Ann Allergy; 1980 Apr; 44(4):200-3. PubMed ID: 7369552 [TBL] [Abstract][Full Text] [Related]
39. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma. Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591 [TBL] [Abstract][Full Text] [Related]
40. Conversion of COPD patients from multiple to single dose theophylline. Serum levels and symptom comparison. Chetty KG; Despars JA; Giron A; Light RW Chest; 1991 Oct; 100(4):1064-7. PubMed ID: 1914559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]